Does SERPLULIMAB Cause Off label use? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Off label use have been filed in association with SERPLULIMAB. This represents 5.8% of all adverse event reports for SERPLULIMAB.
8
Reports of Off label use with SERPLULIMAB
5.8%
of all SERPLULIMAB reports
6
Deaths
0
Hospitalizations
How Dangerous Is Off label use From SERPLULIMAB?
Of the 8 reports, 6 (75.0%) resulted in death, and 2 (25.0%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SERPLULIMAB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does SERPLULIMAB Cause?
Neutrophil count decreased (19)
Platelet count decreased (18)
Pneumonia (17)
White blood cell count decreased (17)
Anaemia (15)
Myelosuppression (13)
Neutropenia (11)
Nausea (10)
Thrombocytopenia (10)
Pneumonitis (8)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which SERPLULIMAB Alternatives Have Lower Off label use Risk?
SERPLULIMAB vs SERTRALINE
SERPLULIMAB vs SEVELAMER
SERPLULIMAB vs SEVOFLURANE
SERPLULIMAB vs SILDENAFIL
SERPLULIMAB vs SILTUXIMAB